Zobrazeno 1 - 10
of 108
pro vyhledávání: '"Marisa Cabeza"'
Autor:
Juan C. Lopez-Lezama, Marisa Cabeza, Yvonne Heuze, Araceli Sánchez, José L. Rojas, Norma A. Valencia-Islas
Publikováno v:
Pharmaceutical Sciences, Vol 28, Iss 3, Pp 433-442 (2022)
Background: Benign Prostatic Hyperplasia (BPH), and Prostate Cancer (PCa) are androgen-dependent diseases. PPCa is associated with excessive signalling of the androgen receptor (AR) due to the binding of 5α-dihydrotestosterone (5α-DHT) and testoste
Externí odkaz:
https://doaj.org/article/ee3ab88ff31944378ce8651dc2c8698b
Publikováno v:
Latin American Journal of Development. 4:2060-2075
L-glutamic acid and ϒ-aminobutyric acid (GABA) show similar physicochemical properties, so separating them by thin-layer chromatography (TLC) is difficult. TLC is currently a widely used method because of its simplicity, flexibility, and low cost co
Autor:
Karen Nayelly Córdova Franco, Gladys Jaquelinne Nieves Zamudio, †Eugene Bratoeff, Marisa Cabeza Salinas, Guillermina Yazmín Arellano Salazar
Publikováno v:
Latin American Journal of Development. 4:967-971
Se sintetizaron 3β-ésteres 17-metoxilados derivados de la deshidroepiandrosterona con el fin de ser utilizados como agentes terapéuticos para el tratamiento de la Hiperplasia Prostática Benigna (HPB) o el Cáncer de Próstata (CaP), ya sea median
Publikováno v:
Current Enzyme Inhibition. 18:19-31
Background: Testosterone circulating levels decrease in aging. This fact affects the emotional response to captivating pictures. Therefore, naturally increasing androgens within neurons could be a way to improve the mood of aged people. Objective: Th
Publikováno v:
Current Enzyme Inhibition. 17:16-25
Introduction: 5α-reductase inhibitors have been proven useful for the treatment of prostate diseases, which can be due to the unregulated activity of 5α-reductase enzyme. This study was focused on determining the activity of four different derivati
Publikováno v:
Endocrine Abstracts.
Publikováno v:
Endocrine Abstracts.
Publikováno v:
Current Enzyme Inhibition. 15:179-189
Background:Benign prostatic hyperplasia and prostate cancer are androgen-dependent diseases, and dihydrotestosterone (DHT), a 5α-reduced metabolite of testosterone (T), has been implicated as a causative factor in the progression of these diseases.
Autor:
Marisa Cabeza, José L. Rojas, Norma Angélica Valencia-Islas, Juan Carlos Lopez-Lezama, Araceli Sánchez, Yvonne Heuze
Publikováno v:
Pharmaceutical Sciences.
Background: Benign Prostatic Hyperplasia (BPH), and Prostate Cancer (PCa) are androgen-dependent diseases. PCa is associated with excessive signalling of the androgen receptor (AR) due to the binding of 5α-DHT and T. BPH is related to high levels of
Publikováno v:
Endocrine Abstracts.